Feng Chi Biotech Corp.

6744

TW0006744006

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-21 EDT			5-day change	1st Jan Change
22.7 ^TWD	-0.22%		-1.30%	+2.25%

04-08	Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Feng Chi Biotech Corp. has completed an IPO in the amount of TWD 19.88 million.

September 24, 2019 at 12:00 am

Feng Chi Biotech Corp. has completed an IPO in the amount of TWD 19.88 million. Security Name: Shares Security Type: Common Stock Securities Offered: 710,000 PriceRange: TWD 28

Latest news about Feng Chi Biotech Corp.

Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-08	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-12	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-18	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-08	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-10	CI
Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Feng Chi Biotech Corp. has completed an IPO in the amount of TWD 19.88 million.	19-09-24	CI
Feng Chi Biotech Corp. has filed an IPO in the amount of TWD 19.88 million.	19-06-24	CI

FENG CHI BIOTECH CORP. is a Taiwan-based Company mainly engaged in the production of medical testing reagents. The Companyâs products include prenatal and neonatal testing reagents and instruments, genetic testing analysis and development services, research instruments and reagents, industrial microbiology and food testing reagents, and among others. The company's products are mainly sold to Taiwan, China mainland, Japan, South Korea, Southeast Asia and India, as well as other overseas regions.

Sector

Advanced Medical Equipment & Technology

More about the company